Search results for "Chagas"

showing 10 items of 47 documents

Análisis poblacional y filogeográfico de vectores de la enfermedad de Chagas en Perú basado en análisis multigénicos del ADN ribosomal y mitocondrial

2017

La enfermedad de Chagas, cuyo agente causal es Trypanosoma cruzi, constituye un grave problema de salud pública en toda Latinoamérica. La principal forma de transmisión es la vectorial, de la que son responsables hemípteros redúvidos de la subfamilia Triatominae adaptados a los hábitats doméstico y peridoméstico. Puesto que el parásito se mantiene en un ciclo zoonótico silvestre y es imposible de eliminar, la principal forma de lucha contra la transmisión vectorial consiste en la eliminación de las poblaciones domiciliadas del vector. Los estudios moleculares constituyen una herramienta de gran utilidad a la hora de planificar las campañas de control vectorial, puesto que permiten conocer y…

perúfilogeniatriatominaeadn ribosomal (its-1 5.8s its-2):CIENCIAS MÉDICAS ::Patología::Parasitología [UNESCO]filogeografiaUNESCO::CIENCIAS MÉDICAS ::Patología::Parasitologíaadn mitocondrial (16s nd1 coi cytb)genética poblacionalhaplotipaje molecularenfermedad de chagas
researchProduct

Triatomine vectors of Trypanosoma cruzi: a molecular perspective based on nuclear ribosomal DNA markers.

2002

Chagas disease (American trypanosomiasis) is mainly transmitted by blood-sucking bugs of the reduviid subfamily Triatominae (Hemiptera: Prosorrhyncha). Control strategies are directed mainly against these insect vectors, as no vaccine is available and, except in the very early stage of infection, there is no effective chemotherapy. Studies of deoxyribonucleic acid (DNA) will lead to major advances in our knowledge of Triatominae and their relationships to Chagas disease transmission, epidemiology and control. Analyses of complete sequences of nuclear genes coding for ribosomal ribonucleic acid (rRNA) (rRNA genes) and spacers furnish significant information at the levels of higher taxons, ge…

Chagas diseaseGenetic MarkersNuclear geneTrypanosoma cruzi18S ribosomal RNAPhylogeneticsmedicineAnimalsHumansChagas DiseaseInternal transcribed spacerTriatominaeRibosomal DNAPhylogenyGeneticsbiologyPublic Health Environmental and Occupational HealthGeneral MedicineRibosomal RNAmedicine.diseasebiology.organism_classificationInsect VectorsInfectious DiseasesRNA RibosomalParasitologyTriatominaeTransactions of the Royal Society of Tropical Medicine and Hygiene
researchProduct

Antiparasitic Effect of Stilbene and Terphenyl Compounds against Trypanosoma cruzi Parasites

2021

AbstractBackgroundChagas disease, also known as American trypanosomiasis, is a potentially life-threatening illness caused by the protozoan parasite Trypanosoma cruzi. No progress in the treatment of this pathology has been made since Nifurtimox was introduced more than fifty years ago and is considered very aggressive and may cause several adverse effects. Currently, this drug has severe limitations, including high frequency of undesirable side effects and limited efficacy and availability and the research to discover new drugs for the treatment of Chagas disease is imperative. Many drugs available in the market are natural products as found in nature or compounds designed based on the str…

Chagas diseaseAntiparasiticmedicine.drug_classTrypanosoma cruzi<i>Trypanosoma cruzi</i>Pharmaceutical ScienceParasitemiaPharmacologyTrypanosoma cruzi.Pharmacy and materia medicaDrug DiscoverymedicineCytotoxic T cellStilbene ST18NifurtimoxAmastigoteTrypanosoma cruzibiologyChemistryR<i>Trypanosoma cruzi</i>; stilbene ST18; terphenyl TR4biology.organism_classificationmedicine.diseaseRS1-441TrypanosomaMedicineMolecular MedicineTerphenyl TR4medicine.drugPharmaceuticals
researchProduct

Synthesis, biological evaluation and chemometric analysis of indazole derivatives. 1,2-Disubstituted 5-nitroindazolinones, new prototypes of antichag…

2012

Chagas disease chemotherapy, currently based on only two drugs, nifurtimox and benznidazole, is far from satisfactory and therefore the development of new antichagasic compounds remains an important goal. On the basis of antichagasic properties previously described for some 1,2-disubstituted 5-nitroindazolin-3- ones (21, 33) and in order to initiate the optimization of activity of this kind of compounds, we have prepared a series of related analogs (22-32, 34-38, 58 and 59) and tested in vitro these products against epimastigote forms of Trypanosoma cruzi. 2-Benzyl-1-propyl (22), 2-benzyl-1-isopropyl (23) and 2-benzyl-1-butyl (24) derivatives have shown high trypanocidal activity and low un…

Models MolecularDrugChagas diseaseIndazolesStereochemistryTrypanosoma cruzimedia_common.quotation_subjectStructure-Activity Relationshipchemistry.chemical_compoundParasitic Sensitivity TestsDrug DiscoverymedicineNifurtimoxTrypanosoma cruziBiological evaluationmedia_commonPharmacologyIndazoleDose-Response Relationship DrugMolecular StructurebiologyOrganic ChemistryGeneral Medicinemedicine.diseasebiology.organism_classificationTrypanocidal AgentsCombinatorial chemistrychemistryBenznidazolemedicine.drugEuropean Journal of Medicinal Chemistry
researchProduct

American Trypanosomiasis Chagas disease : one hundred years of research

2017

Abstract In understanding biodiversity, taxonomy and systematics work together, although the two terms are often confused. The objective of systematics is to understand the natural mechanisms responsible for the biodiversity, while the task of taxonomy is to set up a useful classification of the organisms concerned. The Triatominae (Hemiptera, Reduviidae) are the vectors of Chagas disease. Their classification faces frequent divergence between the modern concepts of systematics and the traditional, morphologically-based, classification. This chapter revises the main concepts of species in general, and their application to the Triatominae. We summarize the current classification of the vecto…

0301 basic medicineSystematicsESPECEbiologyEcologyVECTEUR030231 tropical medicineBiodiversityDIVERSITE SPECIFIQUETAXONOMIEbiology.organism_classification03 medical and health sciences030104 developmental biology0302 clinical medicineReduviidaeEvolutionary biologyFAMILLEMALADIE DE CHAGASTaxonomy (biology)Triatominae
researchProduct

Application of molecular topology in the prediction of new compounds with anti-trypanosomal cytotoxic activity

2021

La enfermedad de Chagas es una antropozoonosis parasitaria de transmisión mayoritariamente vectorial. Si bien afecta principalmente a América, constituye una de las mayores enfermedades desatendidas a nivel mundial. Solamente dos fármacos con un alto grado de toxicidad se encuentran disponibles para su tratamiento, por lo que es preciso aunar esfuerzos en pos del desarrollo de nuevas drogas antitripanosomales eficaces y con escasos efectos adversos. En este estudio, se aplicó la topología molecular para el desarrollo de un modelo QSAR capaz de predecir la actividad citotóxica antitripanosomal de un grupo de 39 compuestos. El modelo desarrollado mediante análisis lineal discriminante permiti…

Chagas diseaseQuantitative structure–activity relationshipComputational biologyBiologyLinear discriminant analysismedicine.diseaseAntiparasiticsAntiparasitariosChagas3209 Farmacología23 QuímicamedicinePotencyMultiple linear regression analysisMolecular topologyNereis. Interdisciplinary Ibero-American Journal of Methods, Modelling and Simulation.
researchProduct

Chagas Disease Vector Control in a Hyperendemic Setting: The First 11 Years of Intervention in Cochabamba, Bolivia

2014

Background Chagas disease has historically been hyperendemic in the Bolivian Department of Cochabamba. In the early 2000s, an extensive vector control program was implemented; 1.34 million dwelling inspections were conducted to ascertain infestation (2000–2001/2003–2011), with blanket insecticide spraying in 2003–2005 and subsequent survey-spraying cycles targeting residual infestation foci. Here, we assess the effects of this program on dwelling infestation rates (DIRs). Methodology/Principal Findings Program records were used to calculate annual, municipality-level aggregate DIRs (39 municipalities); very high values in 2000–2001 (median: 0.77–0.69) dropped to ∼0.03 from 2004 on. A linear…

Chagas diseaseDisease EcologyBolivialcsh:Arctic medicine. Tropical medicineEndemic Diseaseslcsh:RC955-962EpidemiologyEctoparasitic Infestationsmedicine.disease_causeInsect ControlInfectious Disease EpidemiologyOddsInfestationTriatoma infestansparasitic diseasesmedicineMedicine and Health SciencesParasitic DiseasesAnimalsHumansChagas DiseasePublic and Occupational HealthTriatomaEctoparasitic infestationProtozoan InfectionsbiologyEcologylcsh:Public aspects of medicinePublic Health Environmental and Occupational Healthlcsh:RA1-1270Odds ratiomedicine.diseasebiology.organism_classificationTropical DiseasesConfidence intervalInfectious DiseasesTriatomaEpidemiological MonitoringDemographyResearch ArticleNeglected Tropical DiseasesPLoS Neglected Tropical Diseases
researchProduct

Ligand-based discovery of novel trypanosomicidal drug-like compounds: In silico identification and experimental support

2010

Abstract Two-dimensional bond-based linear indices and linear discriminant analysis are used in this report to perform a quantitative structure–activity relationship study to identify new trypanosomicidal compounds. A database with 143 anti-trypanosomal and 297 compounds having other clinical uses, are utilized to develop the theoretical models. The best discriminant models computed using bond-based linear indices provides accuracies greater than 90 for both training and test sets. Our models identify as anti-trypanosomals five out of nine compounds of a set of already-synthesized substances. The in vitro anti-trypanosomal activity of this set against epimastigote forms of Trypanosoma cruzi…

Databases FactualMolecular modelCell SurvivalStereochemistryTrypanosoma cruziIn silicoNitro compoundQuantitative Structure-Activity RelationshipComputational biologyLigandsChemometricsDrug DiscoveryAnimalsHumansChagas DiseaseTrypanosoma cruziAmastigotePharmacologychemistry.chemical_classificationLife Cycle StagesbiologyOrganic ChemistryDiscriminant AnalysisBiological activityGeneral MedicineFibroblastsModels Theoreticalbiology.organism_classificationLinear discriminant analysisTrypanocidal AgentsHigh-Throughput Screening AssayschemistryAlgorithmsSoftwareEuropean Journal of Medicinal Chemistry
researchProduct

New polyamine drugs as more effective antichagas agents than benznidazole in both the acute and chronic phases.

2018

Abstract Despite the continuous research effort that has been made in recent years to find ways to treat the potentially life threatening Chagas disease (CD), this remains the third most important infectious disease in Latin America. CD is an important public health problem affecting 6–7 million people. Since the need to search for new drugs for the treatment of DC persists, in this article we present a panel of new polyamines based on the tripodal structure of tris(2-aminomethyl)amine (tren) that can be prepared at low cost with high yields. Moreover, these polyamines present the characteristic of being water-soluble and resistant to the acidic pH values of stomach, which would allow their…

Chagas diseaseTrypanosoma cruziPharmacology01 natural sciencesMicrobodies03 medical and health scienceschemistry.chemical_compoundIn vivoOral administrationDrug DiscoverymedicinePolyaminesAnimalsHumansChagas DiseaseTrypanosoma cruzi030304 developmental biologyPharmacology0303 health sciencesFluorenesbiology010405 organic chemistryOrganic ChemistryGeneral Medicinemedicine.diseasebiology.organism_classificationTrypanocidal Agents0104 chemical scienceschemistrySolubilityInfectious disease (medical specialty)BenznidazoleNitroimidazolesDrug DesignToxicityAcute DiseaseChronic DiseasePolyaminemedicine.drugEuropean journal of medicinal chemistry
researchProduct

Synthetic single and double aza-scorpiand macrocycles acting as inhibitors of the antioxidant enzymes iron superoxide dismutase and trypanothione red…

2014

The anti-chagasic activity of a series of eleven derivatives of aza-scorpiand-like macrocycles, some of them newly synthesised, was assayed. The four compounds with the best selectivity indices in vitro were subjected to in vivo assays. Tests in a murine model of the acute phase of Chagas disease showed a two-fold reduction in parasitaemia compared to that with benznidazole. Furthermore, compounds 7 and 11, with 4-pyridine and phenanthroline substituents in the lateral chain, caused a remarkable decrease in parasitaemia reactivation during the chronic phase after inducing immunosuppression in mice. These activity studies were complemented by measuring their inhibitory effect towards the ant…

chemistry.chemical_classificationChagas diseaseAntioxidantbiologyChemistryStereochemistryGeneral Chemical EngineeringPhenanthrolinemedicine.medical_treatmentGeneral Chemistrybiology.organism_classificationmedicine.diseaseIn vitrochemistry.chemical_compoundEnzymeBiochemistryBenznidazoleIn vivomedicineTrypanosoma cruzimedicine.drugRSC Adv.
researchProduct